Literature DB >> 25535133

Expression and significance of glucosylceramide synthase in colorectal carcinoma tissues.

C Wang1, J N Liu, L Xu, Y L Mu, P Sun.   

Abstract

OBJECTIVE: To investigate the impression of glucosylceramide synthase (GCS) in colorectal carcinoma tissues.
MATERIALS AND METHODS: Immunohistochemical method was used to detect the expression of GCS in 188 cases of colorectal carcinoma tissues and 80 cases of non-cancerous colorectal tissues. The expression of GCS and the relation with age, gender, tumor location, Tumor stage, differentiation, lymph node metastasis were analyzed. Thus, we further discussed whether to accept neoadjuvant chemotherapy can affect the expression of GCS.
RESULTS: GCS was overexpressed in colorectal carcinoma tissues compared with non-cancerous colorectal tissues; the expression of GCS was associated with lymph node metastasis, but not associated with age, gender, tumor location, differentiation and Tumor stage. What's more, the positive expression rate of GCS in patients who receiving neoadjuvant chemotherapy was higher than that in untreated patients.
CONCLUSIONS: GCS was upregulated in colorectal carcinoma tissues. It might not only play an important role in controlling the generation and progression of colorectal carcinoma, but also be a factor of MDR.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25535133

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  3 in total

1.  Altered Levels of Serum Ceramide, Sphingosine and Sphingomyelin Are Associated with Colorectal Cancer: A Retrospective Pilot Study.

Authors:  Duska Separovic; Anthony F Shields; Philip A Philip; Jacek Bielawski; Alicja Bielawska; Jason S Pierce; Adi L Tarca
Journal:  Anticancer Res       Date:  2017-03       Impact factor: 2.480

Review 2.  Novel Sphingolipid-Based Cancer Therapeutics in the Personalized Medicine Era.

Authors:  Jeremy Shaw; Pedro Costa-Pinheiro; Logan Patterson; Kelly Drews; Sarah Spiegel; Mark Kester
Journal:  Adv Cancer Res       Date:  2018-06-19       Impact factor: 6.242

3.  Inhibition of Ceramide Glycosylation Enhances Cisplatin Sensitivity in Cholangiocarcinoma by Limiting the Activation of the ERK Signaling Pathway.

Authors:  Piyasiri Chueakwon; Peeranat Jatooratthawichot; Krajang Talabnin; James R Ketudat Cairns; Chutima Talabnin
Journal:  Life (Basel)       Date:  2022-02-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.